PipelinePharma Logo

Generics

Originals

Biosimilars

Medical devices

Nutraceuticals 5

Filters

Gymnema sylvestre extract manufacturers

5 products found

Filters

5 products found

gymnema sylvestre extract + momordica charantia oil + trigonella foenum graecum + phylanthus niruri extract + cinnamon extract

Capsules, enteric coated 40mg

Country of origin
United States
GMP approvals
FDA, EU GMP
Recommended use
Diabetes supplements
Product description
Product is a premium Herbal Dietary Supplement with proven efficacy in promoting a healthy glycemic response, energy levels and metabolism of carbs and fats.Product has a unique formula, composed by 9 natural ingredients which is supported by 10 years of R&D. As a Herbal Supplement, Product is mainly used and recommended for people with IFG (Impaired Fasting Glucose). Additionally, mounting clinical evidence also supports the use of Product as an adjuvant to first-line oral antidiabetes drugs in patients with diagnosed Type-2 Diabetes, especially in cases where those fail to achieve adequate glycemic control.
Registered in
Bosnia And Herzegovina , Hungary , Italy , Kosovo , North Macedonia , Montenegro , Romania , Serbia , Slovenia , Spain , United States
Available for
Manufacturer's brand
MAs for sale
Australia , Austria , Kosovo , North Macedonia , Montenegro , Romania , Serbia , Slovenia , United Kingdom , United States
Manufacturer #26858

mulberry leaf extract + gymnema sylvestre extract + vitamin c + vitamin e + vitamin b6

Tablets 200 mg + 200 mg + 40 mg + 6 mg + 0.7 mg

Country of origin
European Union
GMP approvals
EU GMP
Recommended use
Slimming supplements
Product description
Folic acid 200 μg, chromium 20 μg, vitamin D 12.5 μg, vitamin B12 1.25 μg. Glycemic and weight control
Manufacturer #11864
A pharmaceutical manufacturer based in the EU that is active in 20+ countries worldwide selling its products in EU, CIS, LATAM, and South-East Asia for 30+ years. Key production lines are Rx medicines, OTC drugs, and dietary supplements with EU GMP certification. The company's main therapeutic areas include oncology, cardiology, psychiatry, and internal medicine. The company provides eCTD format dossiers as well as BE studies and stability studies.

Manufacturer usually replies in 7 days

cinnamon bark + gymnema sylvestre extract + banaba + vitamin b8 + chromium picolinate

Capsules 213 mg + 150 mg + 33 mg + 100 mcg + 60 mcg

Country of origin
European Union
Recommended use
Diabetes supplements
Product description
A blood sugar level supporting combination of three standardised and scientifically proven plant extracts, biotin and chromium. The cinnamon present is a water extract that is well tolerated.
Manufacturer #28075

Manufacturer usually replies in 19 days

Want to see all 5 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation